皮康王品牌怎么样 申请店铺

我要投票 皮康王在保健药品行业中的票数:15 更新时间:2024-11-23
皮康王是哪个国家的品牌?「皮康王」是 拜耳医药保健有限公司 旗下著名品牌。该品牌发源于云南省昆明市,在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
皮康王怎么样


“皮康王”最初由上海部队院校研制成功,具有神秘的军队血统。曾因帮助老山前线部队解决了因湿热环境引发的脚癣、体癣、股癣及皮肤瘙痒等问题,被誉为“皮疾克星”。后在国家政策放开的情况下由滇虹药业最早获得“军转民”的生产资格,于1993年隆重上市。

滇虹药业集团前身为中美合资昆明滇虹药业有限公司,系由滇虹天然药物厂与美国大东企业于1997年合资设立,承继1993年注册成立的滇虹天然药物厂的全部业务,设立至今始终由中方控股。2012年,昆明滇虹药业有限公司改制变更为滇虹药业集团股份有限公司。2014年3月,拜耳集团完成对滇虹药业集团公司所有股份的收购。滇虹药业集团公司正式成为拜耳集团子公司。

滇虹药业集团是一家研发导向型、集研发、生产和营销为一体的现代化制药企业集团。滇虹药业现有员工3000余名,营销网络覆盖全国乃至东南亚国家及非洲地区。作为云药产业发展的中坚力量,滇虹药业勇于创新、积极开拓,已成长为中国医药行业的知名企业。

通过持续的品牌建设,滇虹药业主品牌“康王”以其广泛的美誉度和影响力,经国家工商行政管理总局及最高人民法院联合认定为“中国驰名商标”,同时上榜“亚洲最具价值500强品牌”。集团旗下产品以质量可靠、疗效确切赢得众多患者青睐。其中包括被誉为“去屑专家”的“康王发用洗剂”以及被誉为“皮疾克星”的“皮康王”、妇科知名产品“丹莪妇康煎膏”等一批享誉国内外的品牌产品。

伴随企业社会知名度和美誉度的不断提升,公司正式确立了植根于品牌的“以消费者大健康产业为主体,以拓展医药及国际市场为两翼”的“一体两翼”消费者大健康产业发展战略。在这一战略指引下,滇虹药业积极推动中国负责任的自我保健及自我药疗事业进程,推动设立国际自我保健日。同时展开产业整合,打造中药标准化平台,集中优势资源将民族品牌做强做大。

滇虹药业被国家五部委联合认定为“国家级企业技术中心”,被云南省人民政府列为“省重点制药企业”,被中华全国工商联和国家税务总局评为“诚信纳税”企业,被全国总工会和中华全国工商联评为“双爱双评”先进企业。多次荣获国家有关部委、省市区各级政府表彰奖励,多次接待国家和国外领导人、省市领导的参观访问。

依托高质量的产品优势和良好的企业文化积淀,滇虹药业气势如虹,开疆拓土,在大健康产业领域以良好的发展态势傲视同侪。秉持“以人为本、艰苦奋斗、科技兴药”的企业理念,怀着“关注健康,造福人类”的企业追求,滇虹愿与社会各界人士携手,共襄医药产业美好未来。


"King Picon" was originally developed by Shanghai military academy, which has a mysterious military pedigree. He once helped Laoshan front-line army to solve the problems of tinea cruris, tinea corporis, tinea cruris and pruritus caused by humid and hot environment, which was known as "skin disease killer". After the opening of the national policy, Dian Hong pharmaceutical industry was the first to obtain the qualification of "military to civilian" production, which was solemnly listed in 1993. Yunnan Hong Pharmaceutical Group, formerly known as Sino US joint venture Kunming Yunnan Hong Pharmaceutical Co., Ltd., is a joint venture established by Yunnan Hong Natural Pharmaceutical Co., Ltd. and Dadong enterprise of the United States in 1997. It inherits all businesses of Yunnan Hong Natural Pharmaceutical Co., Ltd. registered in 1993 and has been controlled by China ever since its establishment. In 2012, the restructuring of Kunming Dianhong Pharmaceutical Co., Ltd. was changed to Dianhong Pharmaceutical Group Co., Ltd. In March 2014, Bayer Group completed the acquisition of all shares of Dianhong Pharmaceutical Group. Dianhong pharmaceutical group company has officially become a subsidiary of Bayer Group. Dianhong Pharmaceutical Group is a R & D-oriented, research and development, production and marketing as one of the modern pharmaceutical enterprise groups. Dianhong pharmaceutical has more than 3000 employees, and its marketing network covers the whole country, even Southeast Asian countries and Africa. As the backbone of the development of Yunnan pharmaceutical industry, Dianhong pharmaceutical industry has the courage to innovate and actively explore, and has grown into a well-known enterprise in China's pharmaceutical industry. Through continuous brand building, the owner brand of Dianhong Pharmaceutical Co., Ltd. "Kangwang", with its extensive reputation and influence, was jointly recognized as "China's famous trademark" by the State Administration for Industry and Commerce and the Supreme People's court, and listed as "the most valuable 500 brands in Asia". The group's products have won the favor of many patients with reliable quality and exact curative effect. Among them, "Kangwang hair lotion" which is known as "Dandruff removal expert" and "picongwang" which is known as "pixixing" and "Dane Fukang Decoction", which is a famous gynecological product, are well-known brand products at home and abroad. With the continuous improvement of corporate social popularity and reputation, the company has officially established the "one body and two wings" development strategy of consumer health industry, which is rooted in the brand and takes the consumer health industry as the main body and the expansion of medicine and international market as the two wings. Under the guidance of this strategy, Dianhong pharmaceutical actively promotes China's responsible self-care and self medication career, and promotes the establishment of the international self care day. At the same time, we will carry out industrial integration, build a platform for standardization of traditional Chinese medicine, and focus on advantageous resources to strengthen and expand national brands. Dianhong pharmaceutical industry is jointly recognized as "national enterprise technology center" by five ministries and commissions of the state, as "provincial key pharmaceutical enterprise" by Yunnan Provincial People's government, as "honest tax payment" enterprise by all China Federation of industry and Commerce and State Administration of Taxation, and as "double love and double evaluation" advanced enterprise by all China Federation of trade unions and all China Federation of industry and commerce. It has won many awards from relevant national ministries and commissions, provincial and municipal governments at all levels, and received many visits from national and foreign leaders and provincial and municipal leaders. Relying on the advantages of high-quality products and good corporate culture accumulation, Dianhong pharmaceutical industry is in a great momentum, expanding its territory and dominating its peers in the field of big health industry with a good development momentum. Adhering to the enterprise philosophy of "people-oriented, hard work, science and technology to promote medicine" and the enterprise pursuit of "focusing on health and benefiting mankind", Dianhong is willing to work with people from all walks of life to share the bright future of medicine industry.

本文链接: https://brand.waitui.com/3539f7c8f.html 联系电话:010-59218282

千城特选小程序码

7×24h 快讯

三六零:前三季度基于“360智脑”能力开发的互联网ToC端产品直接收入占整体营收不超2%

36氪获悉,三六零发布股票交易异常波动公告,公司于2024年10月31日披露了《三六零安全科技股份有限公司2024年第三季度报告》,2024年1-9月归属于母公司所有者的净利润为-5.79亿元。2024年前三季度,基于“360智脑”能力开发的互联网ToC端产品所产生的直接收入在整体营业收入占比不超过2%,对公司业绩不构成重大影响。

53分钟前

小鹏MONA哨兵模式将于明年一季度上线

36氪获悉,小鹏汽车董事长何小鹏在微博发文,小鹏MONA即将于2025年第一季度推出哨兵模式。

53分钟前

爱婴室:股东拟减持不超过1%公司股份

36氪获悉,爱婴室发布公告,股东莫锐强的一致行动人茂强投资、莫锐伟拟通过集中竞价交易方式合计减持公司股份不超过138.54万股(即不超过公司总股本的1%)。

53分钟前

顺丰控股在香港上市据悉计划将价格定在区间中点

顺丰控股在香港上市据悉计划将价格定在区间中点。(财联社)

53分钟前

欧洲央行副行长:降息路径比降息幅度更重要

欧洲央行副行长Luis de Guindos表示,央行显然在降息的道路上,但每次货币政策会议的降息幅度并没有那么重要。他补充说,明年薪资增长将放缓,并且欧洲央行预计通胀将向2%的目标靠拢。“如果我们对明年的通胀预测确实成为现实,那么货币政策路径是明确的,”他周五在马德里的一次会议上说。“我们是降息50个基点还是25个基点的问题就不那么重要了。”(新浪财经)

53分钟前

本页详细列出关于111医药馆的品牌信息,含品牌所属公司介绍,111医药馆所处行业的品牌地位及优势。
咨询